1,468 Shares in Cencora, Inc. $COR Purchased by Chilton Investment Co. Inc.

Chilton Investment Co. Inc. bought a new stake in Cencora, Inc. (NYSE:COR) in the third quarter, Holdings Channel reports. The fund bought 1,468 shares of the company’s stock, valued at approximately $459,000.

Other large investors have also recently bought and sold shares of the company. IAG Wealth Partners LLC bought a new stake in shares of Cencora during the 3rd quarter worth about $30,000. Vermillion & White Wealth Management Group LLC boosted its holdings in shares of Cencora by 69.4% in the second quarter. Vermillion & White Wealth Management Group LLC now owns 105 shares of the company’s stock valued at $31,000 after acquiring an additional 43 shares in the last quarter. Cloud Capital Management LLC bought a new position in shares of Cencora in the third quarter valued at approximately $31,000. Caitlin John LLC acquired a new position in shares of Cencora during the third quarter valued at approximately $31,000. Finally, Westside Investment Management Inc. increased its stake in shares of Cencora by 200.0% during the third quarter. Westside Investment Management Inc. now owns 105 shares of the company’s stock valued at $33,000 after acquiring an additional 70 shares during the period. Institutional investors and hedge funds own 97.52% of the company’s stock.

Analyst Upgrades and Downgrades

COR has been the subject of a number of research analyst reports. Weiss Ratings upgraded Cencora from a “hold (c+)” rating to a “buy (b)” rating in a research report on Thursday, February 5th. Bank of America lowered their price target on Cencora from $380.00 to $360.00 and set a “neutral” rating on the stock in a research report on Monday, January 5th. JPMorgan Chase & Co. upped their price objective on Cencora from $417.00 to $419.00 and gave the company an “overweight” rating in a report on Tuesday, February 10th. Wall Street Zen lowered Cencora from a “buy” rating to a “hold” rating in a report on Friday, November 28th. Finally, Wells Fargo & Company upped their price target on shares of Cencora from $405.00 to $429.00 and gave the company an “overweight” rating in a report on Tuesday, February 10th. Eleven equities research analysts have rated the stock with a Buy rating and two have assigned a Hold rating to the company’s stock. According to data from MarketBeat.com, the company has an average rating of “Moderate Buy” and an average price target of $399.00.

Cencora Trading Down 0.8%

Shares of NYSE COR opened at $349.69 on Monday. Cencora, Inc. has a 12 month low of $252.49 and a 12 month high of $377.54. The company has a market cap of $68.03 billion, a price-to-earnings ratio of 42.03, a P/E/G ratio of 1.63 and a beta of 0.68. The company has a quick ratio of 0.51, a current ratio of 0.92 and a debt-to-equity ratio of 3.62. The business has a fifty day simple moving average of $355.58 and a 200-day simple moving average of $338.81.

Cencora (NYSE:COR) last issued its quarterly earnings results on Wednesday, February 4th. The company reported $4.08 earnings per share for the quarter, topping analysts’ consensus estimates of $4.04 by $0.04. The firm had revenue of $85.93 billion for the quarter, compared to analysts’ expectations of $86.12 billion. Cencora had a return on equity of 176.54% and a net margin of 0.50%.Cencora’s revenue was up 5.5% on a year-over-year basis. During the same quarter last year, the business posted $3.73 EPS. Sell-side analysts predict that Cencora, Inc. will post 15.37 EPS for the current year.

Cencora Announces Dividend

The company also recently announced a quarterly dividend, which was paid on Monday, March 2nd. Stockholders of record on Friday, February 13th were given a $0.60 dividend. This represents a $2.40 annualized dividend and a dividend yield of 0.7%. The ex-dividend date of this dividend was Friday, February 13th. Cencora’s dividend payout ratio (DPR) is 28.85%.

Insider Transactions at Cencora

In other news, EVP Silvana Battaglia sold 1,677 shares of the business’s stock in a transaction that occurred on Friday, December 19th. The shares were sold at an average price of $345.00, for a total transaction of $578,565.00. Following the sale, the executive vice president owned 18,796 shares in the company, valued at $6,484,620. The trade was a 8.19% decrease in their ownership of the stock. The transaction was disclosed in a legal filing with the Securities & Exchange Commission, which can be accessed through the SEC website. Also, EVP Elizabeth S. Campbell sold 3,351 shares of the company’s stock in a transaction that occurred on Friday, December 19th. The shares were sold at an average price of $342.10, for a total transaction of $1,146,377.10. Following the completion of the sale, the executive vice president owned 23,891 shares of the company’s stock, valued at approximately $8,173,111.10. This trade represents a 12.30% decrease in their position. The SEC filing for this sale provides additional information. Insiders have sold a total of 15,220 shares of company stock valued at $5,282,867 over the last ninety days. Corporate insiders own 0.38% of the company’s stock.

Cencora Company Profile

Cencora (NYSE:COR) is a global healthcare services and pharmaceutical distribution company that provides end-to-end solutions across the pharmaceutical supply chain. The company’s core activities include wholesale drug distribution, specialty drug distribution, and the operation of specialty pharmacies, complemented by logistics, cold-chain management and other fulfillment services designed to support complex and temperature-sensitive therapies.

Beyond physical distribution, Cencora offers a range of commercial and patient-focused services for pharmaceutical manufacturers and healthcare providers.